NeuroMetrix, Inc.
NeuroMetrix, Inc. (NURO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NURO · as of Jun 9, 2026
Key Statistics
Explore NeuroMetrix, Inc. Data
nuro stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
nuro competitorsNURO
APGN
CJJD
CNTG
CRVO
ETAOStock Performance
Full HistoryAbout NeuroMetrix, Inc.
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applicatio…
what is neurometrix, inc. · nuro stock overview · neurometrix, inc. company profile · who is neurometrix, inc. ceo · nuro NASDAQ · neurometrix, inc. headquarters · neurometrix, inc. business segments
About Stock Overview & Key Data
NeuroMetrix, Inc. (NURO) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 22, 2004. As of the latest trading session, NURO stock price is $4.58, with a market capitalization of $9.4M. The stock has returned +19.58% over the past 12 months and +16.54% year-to-date.
According to 2 Wall Street analysts, the consensus rating for NeuroMetrix, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, NeuroMetrix, Inc. reported revenue of $3.0M and net income of -$7.8M. For detailed data — including NeuroMetrix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NeuroMetrix, Inc. (NURO) stock price is $4.58. The stock is traded on NASDAQ under the ticker symbol NURO. The 52-week range is $2.66 – $4.73.